Product Information
BUDESONIDE 0.5 MG/2 ML SUSP is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.6761 per ML under NDC 68180098430. Its NADAC has been published 351 times since Jan 15, 2020.
FDA first approved this application on Nov 9, 2018. Its Orange Book therapeutic-equivalence code is AN.
Strength
.5 mg/2mL
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180098430
Classification
Generic
Dosage Form
SUSPENSION
Route
RESPIRATORY (INHALATION)
Effective Date
9/23/2026
Active Ingredients
BUDESONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA210897FDA Approved
11/9/2018
TE Code
AN
On Market Since
5/21/2019
Pharmacological Classes
Price Statistics
The NADAC for BUDESONIDE 0.5 MG/2 ML SUSP has been published 351 times since Jan 15, 2020, and over the history we have for it it has declined 21.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6761 per ML |
|---|---|
| All-time high | $0.9778 (Apr 16, 2025) |
| All-time low | $0.4949 (Jan 18, 2023) |
| 52-week high | $0.8003 |
| 52-week low | $0.6761 |
| Median price | $0.7303 |
| Average price | $0.7055 |
| Largest weekly change | +30.9% (Aug 23, 2023) |
| Weeks tracked | 351 |
| Tracking since | Jan 15, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the budesonide inhalation market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
budesonide inhalation market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BUDESONIDE 0.5 MG/2 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for BUDESONIDE 0.5 MG/2 ML SUSP, manufactured by Lupin Pharmaceuticals Inc., is $0.6761 per ML (NDC 68180098430), effective Sep 30, 2026.
How has the price of BUDESONIDE 0.5 MG/2 ML SUSP changed over time?
Over the history we have for it, the NADAC for BUDESONIDE 0.5 MG/2 ML SUSP has declined 21.4%. It has been tracked across 351 weekly CMS publications since Jan 15, 2020.
What are the highest and lowest recorded NADAC prices for BUDESONIDE 0.5 MG/2 ML SUSP?
Since Jan 15, 2020, the NADAC for BUDESONIDE 0.5 MG/2 ML SUSP has ranged from a low of $0.4949 (Jan 18, 2023) to a high of $0.9778 (Apr 16, 2025), with a median of $0.7303 per ML.
Are there cheaper alternatives to BUDESONIDE 0.5 MG/2 ML SUSP?
No other NADAC-published product currently shares the active ingredient and strength of BUDESONIDE 0.5 MG/2 ML SUSP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BUDESONIDE 0.5 MG/2 ML SUSP?
BUDESONIDE 0.5 MG/2 ML SUSP (NDC 68180098430) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.